Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis

AIM: To investigate management of patients who develop ipilimumab-mediated enterocolitis, including association of endoscopic findings with steroid-refractory symptoms and utility of infliximab as second-line therapy. METHODS: We retrospectively reviewed all patients at our center with metastatic me...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Animesh, Lipson, Evan J, Sharfman, William H, Brant, Steven R, Lazarev, Mark G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360643/
https://www.ncbi.nlm.nih.gov/pubmed/28373768
http://dx.doi.org/10.3748/wjg.v23.i11.2023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360643/
https://www.ncbi.nlm.nih.gov/pubmed/28373768
http://dx.doi.org/10.3748/wjg.v23.i11.2023

Ejemplares similares